425: Strive, Semler Scientific Detail Merger Communication

Strive, Inc. and Semler Scientific, Inc. issued a communication regarding their proposed business combination, including cautionary forward-looking statements and details on regulatory filings.

Summary

• A communication was posted on X.com by Logan Beirne, Chief Legal Officer of Strive, Inc., and Arshia Sarkhani, Chief Marketing Officer of Strive, on September 22, 2025.
• The communication pertains to Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties related to the transaction.
• Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
• The Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek approval for the proposed transaction.
• The filing identifies Strive, Semler Scientific, and certain directors, executive officers, and employees as potential participants in the solicitation of proxies.
• The communication explicitly states it is not an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is a neutral, procedural disclosure of a communication regarding a proposed merger. It outlines necessary regulatory steps and risks without presenting overtly positive or negative financial results or operational achievements.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

Forward-looking statements indicate expectations regarding the proposed transaction, including strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the combined businesses. Strive intends to file a Registration Statement on Form S-4 to register Class A common stock and include an Information Statement/Proxy Statement/Prospectus.

Industry Context

The filing's mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests a strategic move by Strive or the combined entity to integrate digital asset management into its operations. This is a notable trend among some companies seeking to diversify treasury holdings or align with the evolving digital economy, particularly significant given Semler Scientific's background as a medical device company, implying a potentially transformative strategic direction for the combined entity.

Stakeholder Impact

• Shareholders (Strive): Potential dilution due to the issuance of additional Class A common stock.
• Shareholders (Semler Scientific): Will be asked to approve the proposed transaction and are urged to review regulatory documents.
• Customers: Potential for adverse reactions or changes to business relationships.
• Employees: Potential for changes to employee relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• The Form S-4 will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with any other relevant documents filed with the SEC.

Key Dates

Keywords

Merger, Acquisition, Business Combination, SEC Filing, Form 425, Strive Inc., Semler Scientific Inc., Bitcoin Treasury, Digital Assets, Corporate Governance, Proxy Solicitation